| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000042929 |
| Receipt No. | R000048852 |
| Scientific Title | Multicenter, single-arm prospective observational study |
| Date of disclosure of the study information | 2021/02/28 |
| Last modified on | 2021/01/06 (Ver. 1) |
| Basic information | ||
| Public title | Multicenter prospective cohort study to evaluate renal tubular function after switching from ETV to TAF
- Niigata University study group - |
|
| Acronym | Multicenter prospective cohort study to evaluate renal tubular function after switching from ETV to TAF
- Niigata University study group - |
|
| Scientific Title | Multicenter, single-arm prospective observational study | |
| Scientific Title:Acronym | Multicenter, single-arm prospective observational study | |
| Region |
|
|
| Condition | ||
| Condition | Patients with chronic hepatitis B in currently active treatment with ETV for more than 1year | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to investigate changes in efficacy, safety, and tolerability after switching from ETV to TAF for
patients with chronic hepatitis B in active treatment. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Change in rate of virus suppression on 24 weeks after switching from ETV to TAF. |
| Key secondary outcomes | Change in renal tubular function on 12 weeks after switching from ETV to TAF |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with chronic hepatitis B in currently active treatment with ETV for more than 1year | |||
| Key exclusion criteria | Patients who have a history of hypersensitivity to TAF
|
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Niigata University | ||||||
| Division name | Division of gastroenterology | ||||||
| Zip code | 951-8510 | ||||||
| Address | Niigata Japan | ||||||
| TEL | 0252272207 | ||||||
| hiroteruk@med.niigata-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Niigata University | ||||||
| Division name | Division of gastroenterology | ||||||
| Zip code | 9518510 | ||||||
| Address | Niigata Japan | ||||||
| TEL | 0252272207 | ||||||
| Homepage URL | |||||||
| hiroteruk@med.niigata-u.ac.jp | |||||||
| Sponsor | |
| Institute | niigata university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | niigata universuty |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | NiigataUniversity |
| Address | Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata Japan |
| Tel | 0252272207 |
| hiroteruk@med.niigata-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | observation test |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048852 |